Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

228
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
228

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

PUFFIN: protein unit discovery with functional supervision.

Bioinformatics (Oxford, England)·2026
Same author

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

HemaSphere·2026
Same author

Association Between Obesity and Sex-Related Survival Difference in Lung Cancer.

JCO clinical cancer informatics·2026
Same author

Characteristics, treatment and survival of patients with chondrosarcoma in five European countries: a DARWIN EU® cohort study.

Acta oncologica (Stockholm, Sweden)·2026
Same author

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Molecular oncology·2026
Same author

Deep cytomorphology identifies erythroid skewing and monocytic morphology to predict TKI sensitivity in CML patients.

HemaSphere·2026

相关实验视频

Updated: Jan 11, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.3K

提高严重中性缺陷症预测:对在真实世界数据上训练的机器学习模型的PKPD信息标签.

Conor J O'Hanlon1,2, Jonas Denck1, Elif Ozkirimli1

  • 1Roche Informatics, F. Hoffmann-La Roche AG, Kaiseraugst, Switzerland.

Clinical pharmacology and therapeutics
|November 10, 2025
PubMed
概括

一个新的药理动力学-药理动力学 (PKPD) 告知标签策略显著改善了机器学习模型,用于预测多塞素诱导的中性质减退风险. 这种方法提高了数据质量和数量,克服了现实世界的数据挑战.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.6K

相关实验视频

Last Updated: Jan 11, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.6K

科学领域:

  • 药理学和机器学习
  • 临床数据科学 临床数据科学
  • 计算生物学 计算生物学

背景情况:

  • 机器学习 (ML) 的现实世界数据 (RWD) 标签受到稀疏和不平衡的阻碍.
  • 准确预测多塞塔克塞尔诱导的中性质素衰竭对于患者的安全至关重要.
  • 现有的方法与RWD的细微差别作斗争,用于预测建模.

研究的目的:

  • 开发和评估一个基于药理动力学和药理动力学 (PKPD) 的标签策略.
  • 为了提高使用ML的多塞塔塞尔诱导的中性质减退的风险预测.
  • 解决RWD中的数据稀疏性和不平衡问题,用于临床结果预测.

主要方法:

  • 开发了一种基于PKPD的标签策略,使用半机械模型模拟来确定中性粒细胞值.
  • 在4248名患者的RWD上训练了三种ML模型 (逻辑回归,XGBoost,TabPFN).
  • 对比PKPD知情标签与仅使用中性粒细胞观测的天真标签方法.

主要成果:

  • 通过PKPD标记方法,标记患者的实例增加了3.4倍 (7,719 vs 2,283).
  • 使用PKPD信息标签训练的ML模型在所有架构中显示出明显优异的预测性能 (AUC-ROC,AUC-PR).
  • 即使与训练集大小相匹配,性能增长也是一致的.

结论:

  • 基于PKPD的标签有效地克服了RWD稀疏性和不平衡性限制.
  • 这一战略提高了ML模型培训标签的数量和质量.
  • 该方法为改善ML的临床结果预测提供了一个强大的和可概括的框架.